February 1, 2018 - January 31, 2023 - Developing Engineered Autologous Leukemia vaccines to Target Residual Leukemic Stem Cells , PI . Sponsor: CIRM TRAN-1, Sponsor Award ID:
October 1, 2017 - September 30, 2022 - Inducing effective anti-leukemic immunity with novel AML vaccines expressing IL15/IL-15Ra/CD80 , PI . Sponsor: Leukemia Lymphoma Society, Sponsor Award ID:
December 1, 2011 - November 30, 2015 - Lentivirus-based positive/negative selection in minimally ablative transplants , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01HL107974
August 6, 2013 - July 31, 2015 - Efficacy and safety of novel CD80 IL15 IL15Ra expressing autologous AML vaccines , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R21CA177284
May 12, 2008 - April 30, 2013 - Neonatal Chemoselection Following Ex Vivo Gene Transfer For Hereditary Disorders , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01HL082665
April 15, 2006 - April 14, 2012 - Tolerance Induction by Neonatal Gene Delivery , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01DK072537
September 20, 2005 - August 31, 2008 - In Vivo Stem Cell Selection in Neonatal Allo-Transplants , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R21DK069430
September 30, 1994 - August 31, 2007 - GENE THERAPY STRATEGIES FOR SICKLE CELL DISEASE , Co-Investigator . Sponsor: NIH, Sponsor Award ID: P01HL053762
September 1, 1999 - August 31, 2004 - SEQUENTIAL PRE AND POSTNATAL GENE THERAPY OF HEMOPHILIA , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01HL062389
April 1, 1978 - March 31, 2004 - NORTHERN CALIFORNIA COMPREHENSIVE SICKLE CELL CENTER , Co-Investigator . Sponsor: NIH, Sponsor Award ID: P60HL020985
March 1, 1992 - July 31, 1997 - ANALYSIS OF B GLOBIN LOCUS REGULATION BY YAC TRANSFER , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K11HL002711